Drug - Lemtrada® (alemtuzumab) [Genzyme Corporation]li Lilly]
Therapeutic area - Multiple Sclerosis
- Patient must have a diagnosis of a relapsing form of multiple sclerosis AND
- Patient has a history of 2 prior treatments with 2 unique multiple sclerosis therapies
As of October 1, 2015, Lemtrada should be billed using HCPCS code Q9979.
MHCP Provider Call Center 651-431-2700 or 800-366-5411